Autopsy report · NCT02551484

Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Healing After Amputation of the Leg

“The patient population presenting in the department has evolved and no longer allows for the recruitment of the necessary number of patients.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 7 months after it had already started.
• Ran for about 5 years 10 months before it stopped.
• 62 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Hospitalier Universitaire Dijon

Sponsor type

University, hospital or other

Conditions

A Stabilized Definitive Prosthesis (Procedure 1); Definitive Prosthesis With a Contact Socket (Procedure 1); Patients in the Initial Phase (Temporary Prosthesis, Rehabilitation) Following Unilateral Post- Transtibial Amputation (Procedure 2)

Interventions

Measurements using NIRS; TCPO2 measurements; 2-minute walk test

Participants

62

Sites

1

Countries

France

Trials that died the same way

• Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
  “Recruitment problems due to change of patient population at site.” (71% match in meaning)
• Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
  “No more patients complying the selection criteria were available for recruitment” (67% match in meaning)
• Daptomycin in Pediatric Patients With Bacterial Meningitis
  “Insufficient patient recruitment” (66% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (66% match in meaning)
• Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
  “Lack of patient population” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.